Research on weight loss and its health effects. Covers GLP-1 injections, companion digital programs, pregnancy guidelines, and asthma benefits.
The international SUMMIT trial found tirzepatide lowered the risk of worsening heart failure events and cardiovascular death in obese adults with preserved ejection fraction. Participants experienced improved health status, physical function, and exercise tolerance compared to placebo.
Scientists have discovered a new weight loss drug target that increases calorie-burning and lowers appetite without causing nausea. The discovery could lead to a new therapy for millions of people with obesity and type 2 diabetes.
A study by the University of Gothenburg found that unclear procedures and distribution of responsibilities among healthcare workers can lead to poor oral health in older adults in nursing homes. The researchers suggest that a more structured process can promote communication and awareness of good oral health practices.
A team of researchers has discovered a previously unknown metabolic pathway involving beta-hydroxybutyrate (BHB), a key ketone body. This finding suggests that ketones have additional roles in the body's metabolic landscape, potentially influencing appetite suppression and weight regulation under ketosis conditions.
A systematic review found that weight-loss interventions were associated with improvements in some polycystic ovary syndrome (PCOS) symptoms, including improved menstrual frequency. The interventions also showed a clinically significant improvement in metabolic markers and hormonal balance.
A study of 260 teens who underwent bariatric surgery at age 13-19 found that over half demonstrated sustained weight loss and resolution of conditions like type 2 diabetes. After 10 years, 55% of participants with type 2 diabetes remained in remission.
A study found that increasing ketones through a keto diet or supplements can change menstrual frequency and intensity in pre-menopausal women. The research suggests that the presence of ketones, rather than weight loss, may regulate women's health.
A study conducted by Hiddo L. Heerspink at the University Medical Center Groningen found that Ozempic reduced protein in urine by 52% and decreased kidney inflammation by 30%, as well as lowering blood pressure and reducing a key measure of heart failure
Medically induced weight loss with GLP-1 receptor agonists can lead to substantial muscle loss, compromising physical strength and immune function. The authors emphasize the need for a multimodal approach combining medication with exercise and nutritional interventions to preserve muscle mass.
A recent study found that the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023, while rates of metabolic bariatric surgery dropped by one quarter. This shift in treatment options has implications for access to comprehensive multidisciplinary care for obesity.
The EAT2 study, led by Dr. Ursula White, investigates the lasting health effects of short-term weight gain and loss on fat tissue and overall health. Participants will undergo a dietary intervention program followed by an eight-week weight loss treatment.
Two studies found that bariatric surgery is more cost-effective in the long term compared to GLP-1 RA weight loss drugs alone. Combining both treatments is even more cost-effective. The use of GLP-1 RA before surgery appears safe and may be a novel approach to treating obesity.
A recent study discovered 14 'skinny genes' associated with significant weight loss in response to regular exercise. Participants who carried more of these genes lost up to 5kg during an eight-week period. Exercise was found to be crucial for unlocking the full potential of these genes, emphasizing the importance of lifestyle changes.
A systematic review and meta-analysis found that weight-loss surgery reduces pancreatic cancer risk among individuals with obesity by 44%, and among those with both obesity and type 2 diabetes by 79%. The study suggests that metabolic-bariatric surgery may play a crucial role in reducing the risk of pancreatic cancer.
A recent study by The Jackson Laboratory reveals that reducing calorie intake can significantly extend the lifespan of mice, with the most robust animals living the longest. However, the researchers found that losing weight on these diets had a negative impact on lifespan in humans.
A new study from the University of Waterloo suggests that men and women should eat different breakfasts to lose weight. The research found that men's metabolisms respond better to high-carbohydrate meals after fasting, while women are better served by higher-fat meals.
A randomized controlled trial found that time-restricted eating (TRE) led to greater improvements in glucose control, weight loss, and fat reduction compared to standard nutrition counseling in adults with metabolic syndrome. TRE resulted in a lower risk of muscle mass loss during weight loss.
A new study finds that preventive health technologies can support healthy routines but also lead to compulsive usage, ultimately harming users. Consumers' experiences with these technologies vary, from increased engagement to reduced interest and obsessive behavior.
A new study demonstrates the potential of semaglutide in treating hidradenitis suppurative (HS) in people with obesity. The results show marked improvements in patient outcomes across several key measures, including reduced flare frequency, improved quality of life, and better glycaemic control.
A technology-assisted health coaching intervention called Goals for Eating and Moving (GEM) was tested in a cluster-randomized controlled trial involving 19 primary care teams. The study found that patients receiving the GEM intervention did not show significant weight loss compared to those receiving enhanced usual care, highlighting ...
A new study found that up to 10 million people in the US could qualify for Medicare-covered semaglutide injections, depending on their level of cardiovascular risk. Those with higher risk scores would be eligible for full or partial coverage, potentially expanding access to this life-saving medication.
A study found that every 1% decrease in BMI leads to a 4% reduction in cardiovascular risk. Blood sugar control also lowers the risk of chronic kidney disease independently of weight change.
A new study from Lund University found that a starch and sucrose-reduced diet is as effective in reducing IBS symptoms as the current recommended FODMAP diet. The study showed significant improvements in 75-80% of patients, with greater weight loss and reduced sugar cravings in the reduction group.
Two studies found breastfeeding after breast cancer diagnosis is safe and feasible for young patients with specific genetic variations, as well as hormone receptor-positive breast cancer survivors. A third study shows a telephone-based coaching program can significantly increase physical activity in overweight patients, potentially imp...
A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide. The study found that medication's active agent, dosage, treatment indication, and persistence with the medication were associated with weight change.
A retrospective cohort study of 3,389 patients with obesity found that semaglutide and liraglutide were associated with significant weight reduction at 1 year. The study suggests that persistent medication coverage, dosage, treatment indication, and patient sex are important factors in determining weight loss outcomes.
Researchers found that semaglutide and tirzepatide led to significant weight loss (9.1% and 21.4%, respectively) and improved blood sugar control in patients with type 1 diabetes. Weight loss was associated with reduced insulin dose, indicating improved insulin resistance.
A study by the University of Gothenburg found that only 3% of lifestyle advice recommendations have positive effects in practice. The researchers suggest alternative community-based interventions for improving public health. The new guideline aims to help policymakers evaluate the effectiveness of such interventions.
The SURPASS-4 trial found that tirzepatide improved blood glucose control and weight loss in adults with type 2 diabetes. Higher doses of tirzepatide and female patients were associated with better long-term outcomes, including reduced risk of cardiovascular events.
A phase 1 trial found that a new oral weight loss drug, Amycretin, resulted in significant weight loss of up to 13% over three months. The drug targets both amylin and glucagon-like peptide-1 (GLP-1) biology, leading to appetite regulation and reduced hunger.
Research highlights the positive impact of bariatric surgery on controlling high blood pressure in people with obesity. Combining data from 18 randomized controlled trials involving over 1,300 participants, studies found that weight-loss surgery consistently improved blood pressure control and lowered cardiovascular disease risk.
A post hoc analysis found semaglutide treatment did not increase the risk of developing depression or suicidal ideation and was associated with a small reduction in depressive symptoms. Monitoring for mental health concerns is essential for individuals with obesity to receive proper support and care.
A new Penn study analyzing data from over 3,500 participants in clinical trials found no increased risk of depressive symptoms, suicidal thoughts, or suicidal behavior among individuals taking semaglutide for weight management. The study's findings provide assurance that the medication does not increase the risk of mental health issues...
A recent study led by Brigham and Women's Hospital found that semaglutide reduced deaths from cardiovascular disease and infections, including COVID-19, in obese and overweight patients. The study involved over 17,000 participants and showed a 19% lower overall death rate compared to placebo.
New studies show semaglutide reduces all-cause death, CV death, and non-CV death in people with overweight or obesity and established cardiovascular disease. The medication also improves heart failure symptoms and physical limitations in those with obesity-related HFpEF, regardless of sex.
A new study estimates that 1 in 7 Medicare beneficiaries with elevated body mass index (BMI) may qualify for semaglutide, a popular weight loss medication. The study found that maximum annual costs to Medicare could exceed $10 billion if different definitions of cardiovascular risk are considered.
A study published in Annals of Internal Medicine found that approximately 61% of Medicare-eligible adults have a BMI of 27 or higher, making them eligible for semaglutide. However, the number of patients who will be eligible depends on how cardiovascular disease is defined, with narrow definitions resulting in only 3.6 million people b...
A KKH study found that exclusively breastfed women with high body mass index (BMI) lost more weight than those with a healthy BMI pre-pregnancy, with an average weight loss of 200 grammes. Women who practiced exclusive breastfeeding retained less postnatal weight compared to mixed feeding or formula feeding.
A large-scale study investigated the relationship between childhood obesity and immune-mediated skin diseases (IMSDs), such as atopic dermatitis and psoriasis. The study found that obese children were more likely to develop these conditions, with changes in body weight affecting their risk of developing these diseases.
A new study published in Frontiers in Nutrition found that a low-fat vegan diet reduces advanced glycation end-products (AGEs) by 73%, associated with an average weight loss of 13 pounds. The reduction came mainly from excluding meat, added fats, and dairy products.
A new study by UC Riverside demonstrates that calorie restriction does not significantly reduce voluntary exercise in mice. Researchers found that mice continued to run at similar levels regardless of the amount of food they ate, challenging the long-held belief that dieting drains workout energy. The study's findings have implications...
A new study published in Acta Paediatrica reports on the physical and psychological state of 19 children and 7 women who were released from Hamas captivity. The returnees suffered from various health complications, including gastrointestinal pathogens and infectious diseases, as well as trauma and poor hygiene-related issues.
A new study by Charles Sturt University in Australia found that exposure to pro-anorexia content on TikTok leads to decreased body image satisfaction and increased internalization of beauty standards. Women who spend more time on the app are also more likely to experience disordered eating behaviors.
A USC study found that prescription fills for semaglutide increased by over 400% between 2021 and 2023, with most prescriptions going to privately insured patients. The study suggests that this may worsen disparities in diabetes and obesity outcomes among Medicaid and Medicare recipients.
The number of semaglutide prescriptions filled reached 2.6 million in 2023, with Wegovy accounting for most fills since its approval in June 2021. Most Wegovy fills were among commercially insured populations, despite the disproportionate burden of obesity in Medicaid and Medicare Part D.
Researchers found that Megamonas degrades intestinal myo-inositol, enhances lipid absorption, and contributes to obesity. The study suggests potential strategies for future obesity management by illustrating the bacterium's mechanism.
Experts advocate for incorporating normalization of blood sugar regulation into diabetes prevention strategies. Studies show that weight loss-induced prediabetes remission can significantly reduce the risk of developing type 2 diabetes, especially when combined with lifestyle changes.
A recent study published in JAMA Pediatrics found that meal-replacement therapy paired with financial incentives resulted in a greater reduction in body mass index compared to MRT alone. The study enrolled 126 adolescents and found that the combination treatment led to a significant decrease in BMI and total body fat mass.
A special issue of the Journal of the Academy of Nutrition and Dietetics explores the effects of various fasting regimens on body weight, cardiometabolic disease risk, and sleep. The study found that time-restricted eating can result in clinically meaningful weight loss and reduction in liver enzymes in adolescents with type 2 diabetes.
Researchers analyzed fecal samples from fat cats undergoing different dietary changes and found striking similarities to human studies, particularly in the presence of short-chain fatty acids. The study suggests that feline gut microbiome shifts may correlate with metabolic outcomes and provide valuable insights for obesity treatment.
Severe obesity can alter metabolism and psyche, leading to impulsive behavior and a willingness to take risks. A study found that massive weight loss improved glucose metabolism and mood, allowing for more metabolically driven decision-making.
A new study found that low energy availability among female athletes impairs performance by up to 18% in short-term tests and increases systemic stress, compromising immune function. Athletes who restrict their food intake experience muscle loss and decreased physical performance.
A review article by Uppsala University researchers highlights the global issue of malnutrition in the sick and elderly, affecting up to 50% of hospital patients in Sweden. Simple measures such as counselling, dietitian collaboration, and nutritional drinks can reverse malnutrition and improve quality of life.
Researchers found that mice lacking certain signal molecules produced during exercise had reduced oxygen consumption and fat burning, leading to increased susceptibility to weight gain. In humans, those producing more of these alternative versions consumed less oxygen and had lower body fat.
A new study found that surgical weight loss significantly reduces widespread pain in Black and Hispanic patients, with the greatest benefit seen within the first three months after surgery. However, disparities persist, with these groups still experiencing a higher pain burden than the general population.
Tirzepatide was associated with significantly greater weight loss than semaglutide in adults with overweight or obesity. Future studies are needed to explore differences in other outcomes.
A new study found that patients prescribed semaglutide for diabetes or weight loss have a higher risk of developing NAION, a potentially blinding eye condition. The study revealed a significant risk increase in diabetic and overweight/obesity patients taking semaglutide.
A new mouse study suggests that elenolic acid can lower blood sugar levels and promote weight loss in obese mice with diabetes. The compound was found to induce the release of metabolic hormones GLP-1 and PYY, leading to improved glucose regulation and insulin sensitivity.
Researchers found that people who achieved weight loss and prediabetes remission had a 76% lower risk of developing type 2 diabetes compared to those who only lost weight. This suggests that normalization of blood sugar levels should be included as a therapeutic goal in guidelines to improve diabetes prevention.
A randomized clinical trial found that combining exercise with glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment was the most effective weight loss strategy while preserving bone health. In contrast, GLP-1RA treatment alone reduced bone mineral density at clinically relevant sites.